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ABSTRACT 
Objective: This study was conducted to formulate curcumin nanoparticles transdermal patches and to evaluate their physical characterization.  
Methods: Curcumin nanoparticles transdermal patches were formulated by the casting evaporation method. Transdermal patches were made using 
combinations of hydroxypropyl methylcellulose (HPMC) and ethyl cellulose (EC) at ratios of 4.5:1.5 for Formula 1 (F1), 4:1 for Formula 2 (F2), 
3.5:1.5 for Formula 3 (F3), 3:2 for Formula 4 (F4), and 2.5:2.5 for Formula 5 (F5). Physical characterization evaluation (organoleptic properties, pH, 
weight uniformity, thickness uniformity, percent moisture content, and tensile strength) was then performed. The permeation of curcumin 
nanoparticles into the skin was evaluated using Franz diffusion cells.  
Results: Curcumin nanoparticles transdermal patches could be formulated by the casting evaporation method with the organoleptic properties 
characterized as smooth, dry, yellow in color, having menthol odor, and transparent. The pH values ranged between 5.0 and 6.0. The thickness of the 
patches ranged from 0.1 to 0.2 mm. The average of the patches’ weight was 0.7 g, and the percent moisture content ranged from 1.0 to 6.0%. The 
tensile strength values were 1.0 to 2.0 N/mm. Curcumin nanoparticles could penetrate into the skin with flux values being 1.271 µg. cm-2 (F1), 0.938 
µg. cm-2 (F2), 0.775 µg. cm-2 (F3), 0.837 µg. cm-2 (F4), and 0.569 µg. cm-2 
Conclusion: All patches met the requirement of the physical characterization for the transdermal patch. 
(F5).  
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Curcumin is a polyphenolic compound that can be found in turmeric. 
Curcumin exerts several activities, including anti-inflammatory 
activity [1]. 
The potency of curcumin as an anti-inflammatory drug is limited 
because it has low bioavailability in the blood because of its poor 
solubility in aqueous media and because curcumin oral 
administration undergoes first-pass metabolism in the 
gastrointestinal tract [2]. To overcome such limitations, curcumin 
can be administrated through the transdermal route. 
Transdermal drug delivery systems are the delivery of drugs 
through various layers of the skin. One of the limitations of the 
transdermal route is that only a few drugs can penetrate into the 
skin [3]. One way to overcome this limitation is by formulating drugs 
as nanoparticles. In our previous work, we formulated curcumin 
nanoparticles from chitosan polymers and tripolyphosphate [4] and 
provided good characteristics of curcumin nanoparticles. The use of 
chitosan could affect the permeation rate of active agents [5]. 
One example of transdermal preparation is a patch. Patch 
preparations have several advantages, namely greater safety and 
convenience in usage, painless usage, and higher precision in dosage 
than other transdermal preparations [6]. 
The research that was conducted by Chauhan SB [7] showed that the 
combination of hydrophilic and hydrophobic polymer could result 
good physical characteristics and increase the effectivity the of 
patch. Based on the description above, in this research, we 
formulated curcumin nanoparticles transdermal patches using the 
evaporation casting method by combining HPMC (water-soluble 
polymer) and EC (water-insoluble polymer) at various ratios and 
evaluated their physical characterization and the permeation of 
curcumin nanoparticles into the skin by using Frans diffusion cells. 
MATERIALS AND METHODS 
Materials 
Curcumin nanoparticles were taken from the Laboratory of 
Pharmaceutics, Faculty of Pharmacy, Halu Oleo University, Kendari, 
Indonesia. Curcumin nanoparticles were formulated from chitosan 
and tripolyphosphate (the reinforcement ionic gelation method) [4]. 
Other materials included HPMC (ShimEtsu, Japan), EC n10 (Hercules, 
USA),chloroform (Merck, Germany), NaOH (Brataco, Indonesia), 
polyethylene glycol 400 (PEG 400) (Merck, Germany), 
dichloromethane (Merck, Germany), potassium dihydrogen 
phosphate (Merck, Germany), ethanol (Brataco, Indonesia), menthol 
(Brataco, Indonesia), white rats (Rattus Norvegicus), and distilled 
water (Brataco, Indonesia). 
Methods 
Formulation of curcumin nanoparticles transdermal patches 
Transdermal patches of curcumin nanoparticles were made by the 
evaporation casting method. Five formulas of curcumin 
nanoparticles transdermal patches were formulated combinations of 
HPMC and EC polymers at ratios: of 4.5:1.5 (F1), 4:1 (F2), 3.5:1.5 
(F3), 3:2 (F4), and 2.5:2.5 (F5). The total polymer weight for each 
formula was 500 mg. The compositions of the curcumin 
nanoparticles transdermal patches can be seen in table 1. 
PEG 400 was used as a plasticizer, and methol was used as a 
permeation enhancer. HPMC was dissolved in 15 ml of a 
dichloromethane-ethanol mixture (1:1) using magnetic stirrer. EC 
and menthol were dissolved in 2 ml of chloroform. The EC and 
menthol solution was then added to the HPMC solution and 
homogenized using a magnetic stirrer. PEG400 was then added to 
the mixture. Ten milligrams of curcumin nanoparticles were added 
to the solution, and the mixture was homogenized using magnetic 
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stirrer for 10 min until the dope solution formed. Ten milliliters 
resulted solution was then poured into a plate and oven-dried at 
30°C for 24 h. The resulted patches were then taken and placed into 
desiccator for further evaluation. 
  
Table 1:Transdermal patches compositions 
Ingredients Formulation code 
F1 F2 F3 F4 F5 
Curcumin nanoparticles (mg) 10 10 10 10 10 
HPMC (mg) 450 400 350 300 250 
EC (mg) 50 100 150 200 250 
PEG400 (%) 30 30 30 30 30 
Menthol (%) 5 5 5 5 5 
 
Physical characterization of transdermal patches 
Organoleptic evaluation 
The organoleptic evaluation was conducted by observing the color, 
odor, and texture of the patches.  
pH evaluation 
The patches were cut (1 x 1 cm2) and immersed into 1 ml of distilled 
water for 2 h at room temperature. pH evaluation was performed by 
placing a universal indicator on the patches’ surfaces for 1 minute. 
pH was then measured [8]. 
Thickness uniformity 
Thickness uniformity was evaluated by a digital micrometer at three 
different points of patches in triplicate. The average thickness of the 
three points was then calculated [9]. 
Weight uniformity 
For each formula, each of the three patches was weighed, and the 
average weight was then calculated [7].  
Percent of moisture content 
The percent of moisture content of the patches was evaluated by 
weighing the patches and then placed them into desiccator for 24 h. 
After 24 h the patches were re-weighed. The percent moisture 
content was calculated by the following formula [10]: 




The tensile strength of the patches was determined by a tensile 
tester (Shimadzu Autograph AG-X, Japan). The patches tested were 
cut 4 x 1 cm2
A permeation study was conducted using back skin of rats. Rats 
were obtained from the Laboratory of Pharmacy Faculty, Halu Oleo 
University. The skin permeation study was performed by using 
modified Frans diffusion cells. The approval number of Ethical 
clearance for animal handling was 2498/UN29.20/PPM/2018. 
Animal experiments cages were made from plastic material with 40 
cm x 30 cm x 12 cm. The cages floor was applied with wood shavings 
(husks). The cage's top was protected with ram wire to prevent mice 
from coming out of the cage. Drink bottles and pellets were placed 
properly in the cages. The purpose of acclimatization is to adapt 
animals with their environment. Animal acclimation was exhibited 
for 7 d [11]. 
in size and placed between cell grips. Force was applied 
to the film until the film was broken. The tensile strength of the 
patches was determined from dial reading in kg. The tensile strength 
of the patches was calculated by the following formula [8]: 




Fresh pieces of white rat skin were placed between donor and 
receptor compartments. The patches were placed above the skin. The 
receptor compartment was filled with 50 ml of phosphate buffer 
solution at pH 7.4 as the diffusion medium. The temperature of the 
medium was set at 37±0.5 °C. The phosphate buffer solution was 
homogenized by magnetic stirrer at 200 rpm. At time intervals of 0, 15, 
30, 45, 60, 90, 120, 180, 240, 300, and 350 min, 3 ml of phosphate 
buffer solution was withdrawn and replaced with 3 ml of fresh 
medium. The permeated curcumin in the acceptor compartment was 
analyzed by a UV VIS spectrophotometer (Jenway, UK) at λ of 421 nm. 
Drug release study 
A drug release study of the patches was conducted by the modified 
paddle over disk method (Erweka DT 820, Germany). The patches were 
placed in the aluminum disk. Five hundred of phosphate buffer solution 
at pH 7.4 was used as a dissolution medium and stirred at 50 rpm. The 
temperature of the medium was maintained at 37±0.5 °C. At time 
intervals 0, 5, 10, 15, 20, 30, 60, 120, 240 and 360 min, 3 ml of medium 
solution was taken and replaced with fresh medium in the same volume. 
The released curcumin was analyzed by a UV VIS spectrophotometer 
(Jenway, UK) at λ of 421 nm. The test was performed in triplicate.  
RESULTS  
Physical characterization of transdermal patches 
The results of the organoleptic evaluation of the five formulas showed 
that all of the formulas generated a smooth surface texture, dry, elastic, 
yellow, menthol-odor, and transparent properties. The curcumin 
nanoparticles transdermal patches are shown in fig. 1. All of the 
physical characterizations of the transdermal patches, including the 
pH, thickness uniformity, weight uniformity, percent moisture content, 
and tensile strength, are shown in table 2 and table 3. 
 
 
Fig. 1: Curcumin nanoparticles transdermal patches
 
Table 2: Physical characterization of transdermal patches 
Formulation code Thickness (mm) Weight (g) Moisture content (%) 
F1 0.16±0.01 0.77±0.02 6.14±0.61 
F2 0.17±0.01 0.75±0.03 5.60±0.72 
F3 0.16±0.01 0.74±0.01 2.70±0.16 
F4 0.21±0.01 0.73±0.01 1.61±0.61 
F5 0.15±0.02 0.76±0.02 1.84±0.15 
*mean±SD= Standard Deviation from the mean, n = 3  
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Table 3: Physical characterization of transdermal patches 
Formulation code pH Tensile strength (N/mm2 Elongation (%) ) 
F1 5 2.35±0.01 140±5 
F2 5 2.25±0.03 144±6 
F3 6 1.60±0.05 160±3 
F4 6 1.43±0.02 100±4 
F5 5 2.31±0.01 140±5 
*mean±SD= Standard Deviation from the mean, n = 3 
 
 
Fig. 2: Profile of theophylline release of curcumin from the transdermal patches 
 
Drug release study 
The results of the drug release study of the curcumin nanoparticles 
transdermal patches showed that at 360 min the curcumin release in 
F1 was higher than those in another formula. The curcumin release 
from the transdermal patches varied from 21.31% to 27.82% (fig. 2). 
Kinetic modeling of drug release 
The R2 values obtained from zero-order, first-order, Higuchi, 
Korsmeyer-Peppas and Hixson-Crowell models show that the 
curcumin release from the transdermal patches was best fitted to 
the Korsmeyer-Peppas model. The R2
Permeation study 
 values obtained in F1 to F5 by 
the Korsmeyer-Peppas model were 0.993, 0.978, 0.988, 0.956, and 
0.965, respectively (table 4).  
The results of the skin permeation study of curcumin nanoparticles 
transdermal patches show that curcumin could penetrate into the skin 
with the percent transport of curcumin in F1 being higher than that in 
other formulas. The percentage of drug permeated in F1 to F5 at 360 
min was 14.24%, 11.08%, 9.46%, 9.89%, and 6.98%, respectively (fig. 




 values obtained from zero-order, first-order, higuchi, korsmeyer-peppas and hixson-crowell models 
R2values 
Zero-order First-order Higuchi Korsmeyer-peppas Hixson-crowell 
F1 0.914 0.927 0.986 0.993 0.923 
F2 0.833 0.842 0.934 0.978 0.839 
F3 0.83 0.837 0.946 0.988 0.835 
F4 0.773 0.782 0.884 0.956 0.779 
F5 0.71 0.718 0.855 0.965 0.716 
 
 
Fig. 3: Skin permeation study of the curcumin nanoparticles transdermal patches 
 
Table 5: Flux values of the curcumin nanoparticles transdermal patches 
Parameter F1 F2 F3 F4 F5 
Flux (µg/cm2 1.271±0.012 ) 0.938±0.018 0.775±0.022 0.837±0.014 0.569±0.015 
*mean±SD= Standard Deviation from the mean, n = 3 
Suryani et al. 




One of the most important components in transdermal patches is 
polymer. In preparation for transdermal patches, hydrophilic 
polymers and hydrophobic polymers are combined at certain ratios to 
control the drug release and mechanical properties of the transdermal 
patches [12]. HPMC is a hydrophilic polymer that has been used in the 
preparation of transdermal patches. In addition, strong and flexible 
transdermal patches can be produced from the preparation of patches 
by HPMC as a polymer. Meanwhile, ethylcellulose is a hydrophobic 
polymer that is non-toxic and non-irritant and, when combined with 
HPMC will produce transdermal patches with better mechanical 
properties than when a single type of polymer is used. HPMC-EC is a 
common combination of polymers used in the preparation of 
transdermal patches and is compatible with a number of drugs [13]. 
Physical characterization of transdermal patches was performed for 
a number of parameters (organoleptic properties, thickness 
uniformity, weight uniformity, moisture content, pH, tensile 
strength, and percent elongation). Uniformity of transdermal 
patches was shown in their organoleptic, thickness, weight, and pH. 
The uniformity of the patches was shown by low standard deviation 
within the formulation. It indicates that the procedure is 
reproducible for transdermal patch formulation [14]. 
The weight of the transdermal patches ranged between 0.73 g and 
0.77g. Formula 1 had a higher weight than the rest of the formulas. The 
difference in weight was influenced by the differences in the 
concentrations of HPMC and EC. Increasing the number of hydrophilic 
polymers such as HPMC directly caused an increase in the weight of 
the patch matrix formed [15]. HPMC as a hydrophilic polymer can 
absorb high humidity, which caused an increase in transdermal patch 
weight and concentration. The thickness of the transdermal patches 
ranged from 0.15–0.21 mm. The thickness of the formulated 
transdermal patches fulfilled the requirement for a transdermal patch 
thickness of less than 1 mm [16]. The surface pH of the transdermal 
patches could affect the stability and comfortability of the use of the 
patches. The surface pH of the formulated transdermal patches lied in 
the pH range of the skin [17]. The results of the moisture content 
evaluation show minimal percentage values of formulated 
transdermal patches ranging from 1.61 to 6.14, ensuring stability and 
protection from microbial contamination. Formula 1 had higher 
percent moisture content than other formulas. An increase in HPMC 
concentration increased the percent moisture content of the 
transdermal patches [7]. The tensile strength evaluation was 
conducted to determine the strength of the transdermal patches using 
various concentrations of the polymer. It also gave a percentage 
percent elongation values to find out about the mechanical and elastic 
properties of the transdermal patches. The tensile strength of the 
formulated transdermal patches ranged from 1.43 to 2.35 N/mm2, 
while the percent elongation ranged from 100 to 160%. 
Curcumin release from the transdermal patches was evaluated to 
predict the reproducibility rate and duration of curcumin action in 
vivo [18]. Cumulative percent curcumin release from the 
transdermal patch at 360 min ranged from 21.31% to 27.82%. It 
could be predicted that in 24 h all curcumin would be released from 
the transdermal patches, and it was found to be satisfactory for 
transdermal patches. The R2 values of the curcumin nanoparticles 
transdermal patches were evaluated by graphical method for zero 
order, first order, Higuchi, Korsmeyer-Peppas, and Hixson-Crowell 
models to predict the kinetic release of curcumin from the 
transdermal patches, and the R2
A skin permeation study was conducted using modified Frans 
diffusion cells. The results show that curcumin nanoparticles could 
penetrate into rat skin. Formulating curcumin as nanoparticles from 
chitosan and tripolyphosphate can generate permeation enhancers 
for curcumin transport into the skin. Chitosan acts as a permeation 
enhancer by opening tight junction and facilitating both paracellular 
and transcellular transport.  
 value closest to 1 was chosen as the 
best model for curcumin release from the transdermal patch. The 
curcumin release from transdermal patch showed the best fit to the 
Korsmeyer-Peppas model, also known as the Power Low [17]. The 
Power Low indicates the limitation of determining the release 
mechanism of curcumin from the transdermal patch.  
CONCLUSION 
Curcumin nanoparticles have been successfully formulated into 
transdermal patches using combinations of HPMC and EC at various 
ratios. Physical characterization of curcumin nanoparticles 
transdermal patches showed the uniformity of curcumin 
nanoparticle transdermal patches. Curcumin can be released from 
the transdermal patch and can be predicted that all curcumin will be 
released in 24 h. Curcumin can penetrate into the skin and 
formulating curcumin nanoparticles. Overall findings from this 
research show that the limitation of oral curcumin administration 
can be solved by formulating curcumin into curcumin nanoparticles 
transdermal patches, especially for inflammation therapy. 
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